Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Latus Bio focuses on developing innovative gene therapy candidates using precision delivery to enhance the lives of patients.
Perceptive specializes in the design, development, and manufacturing of medical devices for the dentistry industry.
March Biosciences is a clinical-stage cell therapy company that develops CAR-T cell strategies to address hematological cancers.
Ignota Labs recognizes that safety errors during the drug discovery process.
Ashvattha Therapeutics is a clinical-stage biopharmaceutical company that develops precision nanomedicines for ophthalmology diseases.
General Proximity is a pioneering future-oriented proximity medicine that envisions the future of medicine.
Generate Biomedicines is a biotech company that combines biology, machine learning, and biological engineering to create biomedicines.
Ozlo Sleep is a science-driven sleep and audio technology company that simplifies sleep rituals without the use of medication.
Starling develops predictive technology to identify chronic illnesses earlier.
PathPresenter is a global image-sharing platform for pathology that connects pathologists with global expertise and provide seamless access.
Rubedo Life Sciences focuses on developing medicines that target the specific cells responsible for aging, known as pathologic cells.
Harbinger Health is a biotechnology company that develops a two-tier testing model for the detection of early cancer with a blood test.
Atomic AI combines machine learning with structural biology to enable the design of RNA-targeted small molecules and RNA-based therapeutics.
Modi Ventures has invested in 37 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Modi Ventures's top investment sectors include Biotechnology, Health Care, Artificial Intelligence (AI), Medical, Life Science. The firm invests across 20 different industry categories.
Among tracked funding rounds, Harbinger Health received $140.0M in a Series B round. Modi Ventures's total known invested capital is $1.9B.
Modi Ventures's average investment size is $43.9M across its portfolio of 37 companies.
Recent Modi Ventures portfolio additions include Latus Bio, Perceptive, March Biosciences, Ignota Labs, Ashvattha Therapeutics. These companies were founded in 2020 or later.